TechCrunch+ roundup: New VC rules, AI biotech investor survey, Instagram ad case study
TechCrunch
DECEMBER 16, 2022
Biotech firms widely use AI and machine learning to reduce R&D spending and bring products to market faster, but “the bigger question for investors is getting a better understanding of what exactly AI is attempting to model and predict,” says Shaq Vayda, principal at Lux Capital. Image Credits: Medcrypt (opens in a new window).
Let's personalize your content